Weevee vaccine

Ended Awarded Last action

Contract number
W911QY18F0007
Awardee
Awarding agency
Obligated
$20,355,673

Award facts

Contract value 40% obligated
  • $43,256,455.04 Current, with exercised options
  • $51,310,335.04 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00046 -$2
Funding Only Action P00045 -$3,609
Change Order P00044 · To design and conduct clinical and nonclinical research studies, develop supporting assays and reagents, conduct process development efforts, interpret and… -$228,258
Funding Only Action P00043 · The requirement is to design and conduct nonclinical and clinical research studies, develop supporting assays and reagents, conduct process development efforts,… $175,603
Funding Only Action P00042 · This order is for the design and conduct of nonclinical and clinical research studies, develop supporting assays and reagents, conduct process development… -$175,603
Funding Only Action P00041 · The department of defense (DOD) supports the development of vaccines that are directed against validated biological warfare (BW) weapons to include bacteria,… $222,361
Change Order P00040 $0
Change Order P00039 $400,400
Supplemental Agreement for work within scope P00038 $288,075
Change Order P00037 -$425,000
Supplemental Agreement for work within scope P00036 $1,466,485
Funding Only Action P00035 · Deobligate funding -$3,405,071
Supplemental Agreement for work within scope P00034 · Fund clin 0006 tularemia efforts and correct clin 0010 values and funding amounts. $663,507
Supplemental Agreement for work within scope P00033 · Weevee vaccine - within scope supplemental agreement for additional studies -$66,073
Other Administrative Action P00032 · Weevee vaccine: incremental funding to clin 0006 $406,980
Supplemental Agreement for work within scope P00031 · Add funding option clin 0010 exercised $735,028
Funding Only Action P00030 $4,398,712
Exercise an Option P00029 · Tularemia r & d effort $3,197,495
Other Administrative Action P00028 · Delete dfars clause 252.245-7002 and add deviation, dfars 252.245-7002 reporting loss of government property (deviation 2020-O0004) (FEB 2020) $0
Supplemental Agreement for work within scope P00027 $50,000
Funding Only Action P00026 $60,000
Other Administrative Action P00025 $276,000
Other Administrative Action P00024 $1,045,341
Other Administrative Action P00023 $500,000
Other Administrative Action P00022 $598,401
Other Administrative Action P00021 $0
Other Administrative Action P00020 $0
Change Order P00019 $0
Other Administrative Action P00018 -$1,500,000
Other Administrative Action P00017 $32,578
Other Administrative Action P00016 $11,492
Other Administrative Action P00015 $560,197
Other Administrative Action P00014 $1,343,650
Other Administrative Action P00013 $865,131
Other Administrative Action P00012 $143,660
Supplemental Agreement for work within scope P00011 $0
Other Administrative Action P00010 $2,782,194
Other Administrative Action P00009 -$1,000,000
Other Administrative Action P00008 $560,197
Other Administrative Action P00007 $0
Other Administrative Action P00006 $596,257
Other Administrative Action P00005 $0
Other Administrative Action P00004 $515,543
Other Administrative Action P00003 -$900,000
Supplemental Agreement for work within scope P00002 $5,014,000
Exercise an Option P00001 $900,000
Original award $250,000
Show all 47

About this award

Written by GovTribe AI ·

Battelle Memorial Institute received a delivery order valued at $51.3 million from the Joint PEO Chemical and Biological Defense to design and conduct clinical and nonclinical research studies for the WEEVEE vaccine program. Under the cost-plus fixed fee arrangement, Battelle is responsible for developing supporting assays and reagents, conducting process development efforts, interpreting and reporting study results, and evaluating advanced development candidates for medical products. The contract, awarded February 9, 2018, with an ultimate completion date of February 11, 2025, supports the Department of Defense's chemical and biological defense initiatives and will be performed in Columbus, Ohio. The award was made without set-aside designation, reflecting open competition.

Battelle has engaged a diverse subcontractor network to execute the vaccine development program, including Envigo Global Services Inc. for non-human primate acquisition and surgical services, Amplifybio LLC for toxicological and nonclinical studies, Texas Biomedical Research Institute for infectious disease modeling, Monogram Biosciences for neutralizing antibody assays, Colorado State University for stability testing programs, and Resilience Government Services for manufacturing of cGMP bulk drug substance and recombinant botulinum vaccine formulations. Additional subcontractors include CMC Pharmaceuticals for release testing, Biosentinel Inc. for non-animal based method development, and Sanford Applied Biosciences for polyclonal antibody production. This contract is issued under the OASIS master Indefinite Delivery/Indefinite Quantity vehicle, providing flexible procurement access to Battelle's extensive scientific and technical capabilities for medical countermeasure development.

Subawards

Subcontractor Amount Awarded
Envigo Global Services Inc. TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND… $833,114
Envigo Global Services Inc. TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND… $1,409,485
Amplifybio LLC TO DESIGN AND CONDUCT CLINICAL AND NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, CONDUCT PROCESS DEVELOPMENT EFFORTS, INTERPRET AND… $57,700
Envigo Global Services Inc. WEEVEE VACCINE Surgical Services Primate; Fecal Testing; Measles Vaccine; Testing SRV/PCR; Testing Viral Profile $218,171
Biosentinel, Inc. WEEVEE VACCINE Development of non-animal based methods $2,921,852

Quick answers

Who was awarded contract W911QY18F0007?

W911QY18F0007 was awarded to Battelle Memorial Institute by ACC Aberdeen Proving Ground (Army Contracting Command) on February 9, 2018.

How much is contract W911QY18F0007 worth?

The government has obligated $20,355,673 on W911QY18F0007. Its current value, with exercised options, is $43,256,455. Its potential value, with all options, is $51,310,335.

Which agency awarded contract W911QY18F0007?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY18F0007, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Is contract W911QY18F0007 an order under another contract?

Yes. W911QY18F0007 is a delivery order under GS00Q14OADU402, an indefinite delivery contract, on One Acquisition Solution for Integrated Services (OASIS).

Was contract W911QY18F0007 competed?

The extent of competition for W911QY18F0007 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login